• Publications
  • Influence
Discontinuation of Peritoneal Dialysis after Late Initiation of Eculizumab in a Case of Familial Atypical Hemolytic-Uremic Syndrome: A Case Report
This case shows that eculizumab treatment for patients with atypical hemolytic-uremic syndrome, even when initiated many months after beginning on dialysis, might offer substantial benefits and improve the patients’ quality of life. Expand
[Practical considerations respecting the clinical use of serum cystatin C as a marker of glomerular filtration].
The routine measurement of cystatine C seems to be warranted for estimating the glomerular filtration rate in patients in whom creatinine synthesis might be impaired, because the estimation error was much higher than what is clinically acceptable, which prevents the interconversion of values. Expand